FDA approves AbbVie’s hepatitis treatment

December 19, 2014 8:00 PM

4 0

FDA approves AbbVie’s hepatitis treatment

AbbVie’s Viekira Pak, a cocktail of several drugs, cured more than 90% of most common form of hepatitis C

U.S. regulators on Friday approved AbbVie Inc.’s new multidrug regimen for hepatitis C, the latest in a wave of new medicines that is transforming treatment of the liver disease.

Read more

To category page

Loading...